Terry . Yvonne Segal

Dr. Terry . Yvonne Segal

University College London Hospitals NHS Foundation Trust, London, City of London, UK
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Archives of Disease in Childhood
Verified
Journal Article
Open access
PDF file
RVR M Viner
R M Viner
TSTerry . Yvonne Segal
Terry . Yvonne Segal
ELE Lichtarowicz-Krynska
E Lichtarowicz-Krynska
PHP Hindmarsh
P Hindmarsh
Aims: To assess prevalence of the insulin resistance syndrome (IRS: obesity, abnormal glucose homoeostasis, dyslipidaemia, and hypertension) in obese UK children and adolescents of different ethnicities and to assess whether fasting data is sufficient to identify IRS in childhood obesity. Methods: A total of 103 obese (BMI >95th centile) children and adolescents 2–18 years of age referred for assessment underwent an oral glucose tolerance test, measurement of fasting lipids, and blood pressure determination. Main outcome measures were prevalence of components of IRS by modified WHO criteria, with IRS defined as ⩾3 components (including obesity). Results: There were 67 girls (65%). BMI z-score ranged from 1.65 to 6.15, with 72% having a z-score ⩾3.0. Abnormal glucose homoeostasis was identified in 46% (hyperinsulinism in 40%, impaired fasting glucose in 0.8%, impaired glucose tolerance in 11%). No subjects had silent type 2 diabetes. Dyslipidaemia was identified in 30% and hypertension in 32%. Thirty one per cent had obesity alone, 36% had two components, 28% had three, and 5% had all four components. Birth weight, BMI, and family history of IRS were not associated with risk of IRS. Higher age increased the risk of IRS; however the syndrome was seen in 30% of children under 12 years. The use of fasting glucose and insulin data for identifying IRS had a sensitivity of 88% and specificity of 100%. Conclusions: One third of obese children and adolescents have the IRS; however type 2 diabetes is rare. Obese children with the IRS may form a high risk group to whom scarce intervention resources should be targeted. Further work is needed to develop appropriate screening programmes for IRS components in significantly obese children.

1 May 2005 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
FSF A Stuart
F A Stuart
TSTerry . Yvonne Segal
Terry . Yvonne Segal
SKS Keady
S Keady
Children and adolescents treated with oral, inhaled, and intravenous corticosteroids (CS) may experience adverse psychological side effects (APSE), including psychotic symptoms. These can occur at any point during treatment, including withdrawal. In this paper the literature on these effects in children and adults is reviewed. From the evidence available, it is not possible to give reliable estimates for incidence or prevalence of APSE, nor clear risk factors. Some evidence is reported to suggest that oral dexamethasone treatment may carry a higher risk of APSE than other CS, but this requires further investigation. There is evidence from the adult literature that higher CS doses increase the risk of APSE. However, the dose response effect is not straightforward or predictable for individuals or groups. This is likely to be a reflection of the complex effects of CS on the central nervous system and the probable interplay between individual susceptibility, disease factors, and external environmental stressors in the emergence of APSE. More research is required to further our understanding of the adverse effects of these clinically valuable agents.

1 March 2009 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
TSTerry . Yvonne Segal
Terry . Yvonne Segal
AMAmeeta Mehta
Ameeta Mehta
AAAntoinette Catherine Anazodo
Antoinette Catherine Anazodo
PHPeter C. Hindmarsh
Peter C. Hindmarsh
MDMehul T. Dattani
Mehul T. Dattani
Background: Delayed puberty can be due to either constitutional delay of growth and puberty (CDGP) or hypogonadotropic hypogonadism (HH). Differentiating between the two using current testing can be difficult. We assessed the utility of a GnRH test in combination with a 3-d and 19-d human chorionic gonadotropin (HCG) test to discriminate between the two conditions. Methods: We performed a retrospective analysis of 43 boys with pubertal delay who required pubertal induction with testosterone. All were followed through puberty; 29 were subsequently diagnosed with CDGP and 14 with HH. A standard GnRH test (2.5 μg/kg) was undertaken and was followed by a short [3 d; n = 38 (13 HH, 25 CDGP)] or extended [19 d; n = 31 (12 HH, 19 CDGP)] HCG stimulation test, or both [n = 27 (11 HH, 16 CDGP)]. Receiver operating characteristic analysis was performed to assess the performance of the tests. Results: Peak testosterone concentrations to both 3-d and 19-d HCG tests were significantly lower in patients with HH compared with CDGP. The 19-d test performed better than the 3-d test, and a combination of the LHRH, 3-d and 19 d HCG test [peak LH cutoff, 2.8 U/liter; peak 3-d testosterone cutoff, 1.04 μg/liter (3.6 nmol/liter); peak 19-d testosterone cutoff, 2.75 μg/liter (9.5 nmol/liter)] gave a sensitivity and a specificity of 100%. Conclusions: Our data suggest that a GnRH test in combination with both a 3-d and 19-d HCG test may aid in differentiating between CDGP and HH.

14 June 2017 in Archives of Disease in Childhood - Education & Practice Edition
Verified
Journal Article
Closed access
PDF file
MDMontserrat Doukrou
Montserrat Doukrou
TSTerry . Yvonne Segal
Terry . Yvonne Segal
Adolescents undergo a period of biological, social and psychosocial development, and each of these domains impacts each other. Psychosocial areas of concern often emerge over the adolescent period (such as mental health conditions, drug use and risky sexual behaviour); those with chronic illness being at higher risk. The paper aims to guide health practitioners on when and how to approach the psychosocial interview with young people and assess areas of risk or concern. This will include putting them at ease, developing rapport, seeing them alone and explaining confidentiality before commencing the assessment. Home, Education/Employment, Eating, Activities, Drugs, Sexuality, Suicidal ideation and Safety (HEEADSSS) is a recognised psychosocial interview framework that allows a better understanding of the young person’s situation and what their specific needs may be. By exploring each section in turn briefly or more fully, it gives the professional an overall impression of the young person’s life and any risky behaviours or concerns. This systematic structure should develop an easily accessible approach to adolescents as a group of patients whatever their developmental stage.

18 July 2022 in Archives of Disease in Childhood
Verified
Journal Article
Open access
PDF file
GBGary Butler
Gary Butler
KAKirpal Adu-Gyamfi
Kirpal Adu-Gyamfi
KCKerry Clarkson
Kerry Clarkson
RKRanna El Khairi
Ranna El Khairi
SKSara Kleczewski
Sara Kleczewski
PCPolly Carmichael
Polly Carmichael
Introduction The destination of transgender and gender variant young people referred by the National Health Service (NHS) Gender Identity Development Service (GIDS) to, and discharged from the two English paediatric endocrine liaison clinics is not known. Methods 1151 young people referred after full assessment by the GIDS; 827 to University College London Hospital since 2008; 324 to Leeds Children’s Hospital since 2013. Discharge categorisation was by agreed criteria. Eleven emigrated and 51 self-discharged. 1089 had known outcomes. Results 999/1089 (91.7%) continued identifying as gender variant. 867/999 (86.8%) were discharged to adult gender identity clinics (GICs). 166/867 (19.1%) of these were <16 years and 701/867 (80.9%) ≥16 years at initial endocrine referral. No sex differences were seen. 38/999 (3.8%) opted for non-NHS services. 90/1089 ceased identifying as gender variant. In 32/1089 (2.9%), this was subsequent to their first clinic appointment. 58/1089 (5.3%) stopped treatment either with the gonadotropin releasing hormone analogue (GnRHa) or gender-affirming hormones (GAH) and reverted to their birth gender: <16 years (20/217; 9.2%); ≥16 years (38/872; 4.4%). Subdividing further, 16/217 (7.4%) <16 years ceased GnRHa and 4/217 (1.8%) after GAH. Of those ≥16 years, 33/872 (3.8%) ceased GnRHa and 5/872 (0.6%) GAH. Conclusions At discharge, 91.7% continued as transgender or gender variant, 86.8% sought ongoing care through NHS GICs. 2.9% ceased identifying as transgender after an initial consultation prior to any endocrine intervention and 5.3% stopped treatment either with GnRHa or GAH, a higher proportion in the <16 year compared with the ≥16 year groups.

1 January 2005 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
TSTerry . Yvonne Segal
Terry . Yvonne Segal
PHP.C. Hindmarsh
P.C. Hindmarsh
RVR.M. Viner
R.M. Viner
Article Disturbed Adrenal Function in Adolescents with Chronic Fatigue Syndrome was published on March 1, 2005 in the journal Journal of Pediatric Endocrinology and Metabolism (volume 18, issue 3).